Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inari Medical Inc
(NQ:
NARI
)
37.43
-0.50 (-1.32%)
Streaming Delayed Price
Updated: 1:37 PM EDT, Apr 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
886,960
Open
37.95
Bid (Size)
37.41 (4)
Ask (Size)
37.45 (1)
Prev. Close
37.93
Today's Range
36.81 - 38.36
52wk Range
37.92 - 71.85
Shares Outstanding
54,313,676
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 22, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 19, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Performance
YTD
-43.08%
-43.08%
1 Month
-11.70%
-11.70%
3 Month
-34.96%
-34.96%
6 Month
-34.85%
-34.85%
1 Year
-46.35%
-46.35%
More News
Read More
Inari Medical to Announce First Quarter 2024 Financial Results
April 17, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
What 8 Analyst Ratings Have To Say About Inari Medical
April 12, 2024
Via
Benzinga
Forecasting The Future: 7 Analyst Projections For Inari Medical
March 22, 2024
Via
Benzinga
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 15, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Announces the Release of 2023 Ethos and Sustainability Report
April 11, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Lowey Dannenberg, P.C. is Investigating Inari Medical Inc. (“Inari” or the “Company”) (NASDAQ:NARI) for Potential Violations of the Federal Securities Laws and Encourages Investors with more than $50,000 in Losses to Contact the Firm
April 11, 2024
From
Lowey Dannenberg, P.C.
Via
GlobeNewswire
Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives
April 02, 2024
From
Inari Medical, Inc.
Via
GlobeNewswire
Market Cap Game Show: Andy Cross vs. Bill Mann
March 30, 2024
Via
The Motley Fool
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical following Inari Medicals Disclosure of a DOJ Investigation related to Anti-Kickback laws
March 20, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI) Investigated by Kaplan Fox & Kilsheimer LLP for Potential Securities Law Violations following Inari Medicals receipt of a Civil Investigative Demand from the DOJ
March 19, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 18, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical Investigated for Potential Securities Law Violations - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 18, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 17, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Inari Medical has Received a Civil Investigative Demand from the U.S. Department of Justice - Investors of Inari Medical are Encouraged to Contact Kaplan Fox & Kilsheimer LLP
March 17, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
March 16, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Continues its Investigation of Inari Medical Following Inari Medical's Disclosure of a DOJ Investigation Related to Anti-Kickback Laws
March 16, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
March 15, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical in Connection with Inari Medical's Receipt of a Civil Investigative Demand from the U.S. Department of Justice
March 15, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
March 14, 2024
Via
NewMediaWire
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
INARI MEDICAL (NASDAQ: NARI): Kaplan Fox & Kilsheimer LLP Investigates Inari Medical for Potential Securities Law Violations and Encourages Investors to Contact the Firm
March 14, 2024
Via
TheNewswire.com
Topics
Regulatory Compliance
Exposures
Legal
Regulatory
Bragar Eagel & Squire, P.C. Is Investigating SSR, Inari Medical, and Entravision and Encourages Investors to Contact the Firm
March 12, 2024
From
Bragar Eagel & Squire
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.